Vantage Urologic Institute


Urologic Oncology

The physicians and surgeons at the Vantage Urologic Institute focus on comprehensive, personalized, patient-centered treatment of urologic cancers and the development and delivery of new therapies. The Vantage Urologic Institute is a pioneer in the genomic and translational approach to urologic cancer care, including the use of innovative molecular-based techniques to better assess individual patient risk, diagnose, determine prognosis, and to treat.  With genomics, it is possible to evaluate the unique biology of each patient's disease and to predict the likely course of the disease for that individual. In turn, this information makes it possible individualize a management plan, which may potentially improve patient outcomes.

We treat the following urologic cancers:

Prostate Cancer

Bladder Cancer

Kidney Cancer

Testicular Cancer